$TDOC

Catapano Joseph Ronald sold $4K of TDOC

Catapano Joseph Ronald (Chief Accounting Officer) sold 655 shares of Teladoc Health, Inc. (TDOC) at $5.65 on 2026-10-02.

Original reporting
SEC EDGAR · Catapano Joseph Ronald
Published Oct 5, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TDOC
Neutral
high confidence
Mentioned
$TDOC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TDOCNeutralLow
01

Why it matters

The transaction is a routine insider sale with minimal market impact.

02

Market read

Low relevance; the filing is a routine disclosure with negligible trading implications.

03

What to watch

Potential upcoming compensation adjustments or tax planning.

Relevance 3/10Novelty 3/10Timing: after filing

Background

SEC Form 4 filing by Teladoc Health's Chief Accounting Officer reporting a modest open‑market sale.

Company-level read

Ticker impact

$TDOCNeutralHigh confidence
Context

Form 4 shows Chief Accounting Officer sold 655 shares for $3,702, a small insider sale.

Expected impact

likely slight downward pressure as market prices the insider sale.

Evidence & confidence

The sale is small relative to holdings and typical for 10b5-1 plans, so impact is minimal.

Market effects

none

none

none

Counterpoint

The sale could be a signal of insider concern, but size is too small to act on.

Key entities

  • Teladoc Health, Inc.

    US‑listed telehealth provider (ticker TDOC).

  • Catapano Joseph Ronald

    Chief Accounting Officer of Teladoc Health.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TDOCMed

Why is Teladoc stock sliding today?

Teladoc (TDOC) shares fell 2.3% to $5.95 amid leadership transition concerns. The company's CLO resigned, raising governance questions. The stock has declined since Q2 revenue missed expectations and guidance was cut. Analysts have lowered price targets, and institutional selling has increased. The broader market's decline added pressure. TDOC trades near its 52-week low of $4.40.

$TDOCLow

Teladoc nabs insurance veteran as new CFO

Teladoc Health appointed Michael Grasher as its new CFO, effective immediately. Grasher succeeds Mala Murthy, who left in November. He brings over 30 years of experience in insurance and financial services, most recently as CFO of IFG Companies. The move follows Teladoc's recent revenue guidance reduction, partly due to challenges in its mental health unit, BetterHelp.

$TDOCMed

Teladoc appoints insurance executive Michael Grasher as CFO

Teladoc Health named Michael Grasher as its new CFO. Grasher, with over 30 years of experience in insurance, previously served as CFO of IFG Companies. The appointment follows Teladoc's recent revenue forecast cut and challenges in its mental health unit, BetterHelp. Analyst Elizabeth Anderson views the move positively for Teladoc's leadership.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.